måndag den 29 april

Nya PPM: Risk för småbolagsstök

Ellinor Beckett
Stockholmsbörsen
(), idag
-
-

Coegin Pharma AB
BioStock: Coegin Pharma receives final approval for COAK Study (Cision)

2021-10-26 08:45
After complying with the conditions given by the Danish Ethics committee in September, Nordic biotech Coegin Pharma has received the final approval for initiating the phase I/II COAK study in actinic keratosis patients. From the beginning of November, the company will begin patient recruitment, and thus take an important step towards developing a novel treatment for a disease with a large unmet medical need.

Read the full article at biostock.se:

https://www.biostock.se/en/2021/10/coegin-pharma-receives-final-approval-for-coak-study/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/


Coegin Pharma - I dag

{point.key}

Senaste nytt

Visa alla telegram

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex
Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor
Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor
Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror
Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -